The Effects of Mandala Coloring on Perceived Stress Levels and Resilience Among Mothers of Children Hospitalized in a Pediatric Intensive Care Unit
NCT07933744, Not applicable, Completed, Firat University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | The Effects of Mandala Coloring on Perceived Stress Levels and Resilience Among Mothers of Children Hospitalized in a Pediatric Intensive Care Unit | ClinicalTrials.gov |
| NCT number | NCT07933744 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 100 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Firat University | ClinicalTrials.gov |
| Conditions | Mother, Child, Stress | ClinicalTrials.gov |
| Interventions | the mandala coloring activity | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | assessing stress during mandala coloring | 35-40 minutes | The Perceived Stress Scale , developed by Cohen, Kamarck, and Mermelstein , was used to assess the perceived stress levels of mothers. The validity and reliability study of the scale in Turkish was conducted by Bilge et al. The scale consists of 8 items rated on a scale from 0 (Never) to 4 (Very often). Items 4, 5, and 6 are reversely scored. The total score on the scale ranges from 0 to 32, with higher scores indicating a higher level of perceived stress. The scale consists of two subscales: "Perceived Stress" and "Perceived Coping." In the present study, the Cronbach's alpha coefficients for the scale were calculated as 0.83 for the total score, 0.85 for the Perceived Stress subscale, and 0.82 for the Perceived Coping subscale. | ClinicalTrials.gov |
| Secondary | assessing brief resilience during mandala coloring | 35-40 minutes | In order to assess the resilience levels of mothers, the BRS-developed by Smith et al. and validated and tested for reliability in Turkish by Doğan -was used. The scale consists of 6 items rated on a single dimension. Items are scored on a scale from 1 (Not at all applicable) to 5 (Strongly applicable), with the items 2, 4, and 6 reverse-scored. The total possible score on the scale ranges from 6 to 30, with higher scores indicating a higher level of resilience. In this study, the scale's Cronbach's alpha coefficient was found to be 0.89. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)